As a premier event in the field of rheumatology, this year’s Congress promises another bold scientific programme featuring new clinical data and updated treatment guidelines as well as emerging therapies, cutting-edge technologies and patient-centred approaches transforming the RMD landscape.
What’s new for delegates
Additionally, the programme has further been adjusted to better accommodate delegate requests. Abstract and Case Report Submissions are open since 1 October 2025.
“We warmly welcome the media to join us in London as we highlight the global momentum in rheumatic and musculoskeletal diseases”, said Prof Xenofon Baraliakos, EULAR President. “Your coverage helps ensure that the latest research, technologies and treatment advances reach communities, patients and clinicians around the world”.
Exclusive media opportunities
Members of the press are invited to attend the official EULAR press conference on 4 June 2026 to learn more about recent breakthroughs and upcoming challenges in RMD research and care as well as to benefit from one-on-one interview access with expert panellists.
Press credentials and info
To apply for media accreditation or explore the Congress programme, visit: EULAR 2026 - Press Registration
We look forward to welcoming you to London for an inspiring and impactful EULAR 2026 Congress.
About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with RMDs. EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.
Contact
EULAR Communications, communications@eular.org
Notes to Editors